Home Cart Sign in  
Chemical Structure| 864289-85-0 Chemical Structure| 864289-85-0

Structure of C-021
CAS No.: 864289-85-0

Chemical Structure| 864289-85-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

C-021 is a selective CCR4 antagonist, suitable for studying CCR4-related immune and inflammatory diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of C-021

CAS No. :864289-85-0
Formula : C27H41N5O2
M.W : 467.65
SMILES Code : COC1=CC2=NC(N3CCC(N4CCCCC4)CC3)=NC(NC5CCCCCC5)=C2C=C1OC
MDL No. :MFCD18661383
InChI Key :WYVBISCFCHREDA-UHFFFAOYSA-N
Pubchem ID :25141190

Safety of C-021

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of C-021

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
sensory neurons 1 μM To evaluate the direct activation of sensory neurons by CCL22 and its effect on enhancing excitability, results showed that CCL22 could directly activate neurons and enhance their excitability after injury, and these responses were blocked by C-021. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2118238119

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Male albino Swiss mice Chronic constriction injury (CCI) of the sciatic nerve model Intraperitoneal injection (i.p.) 1, 5, 10, or 20 mg/kg (i.p.) Single administration C021 administration dose-dependently diminished neuropathic pain-related behaviors in CCI-exposed mice, including tactile and thermal hypersensitivity. Front Immunol. 2020 Jul 14;11:1241
C57Bl/6 mice Acute liver failure model Intraperitoneal injection 1 mg/kg Once daily for 3 days To assess the role of CCL2 and its receptors in hepatic encephalopathy due to acute liver failure. Results showed that pretreatment with C021 significantly improved neurological outcomes in AOM-treated mice, reduced microglia activation, decreased phosphorylation of ERK1/2, and alleviated AOM-induced cytokine upregulation. J Neuroinflammation. 2014 Jul 10;11:121
Mice Postoperative pain model Intraplantar injection 2 mM Single injection, observed for 1-6 hours To evaluate the inhibitory effect of CCR4 antagonist C-021 on postoperative pain, results showed that C-021 significantly attenuated mechanical hypersensitivity but had no significant effect on thermal hypersensitivity. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2118238119
C57BL/6J mice HCC orthotopic implantation models Intraperitoneal injection 10 μmol/kg Every 3 days for 9 weeks To evaluate the inhibitory effect of C-021 on SOX12-mediated HCC metastasis Adv Sci (Weinh). 2024 Sep;11(36):e2310304

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.14mL

0.43mL

0.21mL

10.69mL

2.14mL

1.07mL

21.38mL

4.28mL

2.14mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories